94 results
8-K
EX-99.1
ESTA
Establishment Labs Holdings Inc
28 Feb 24
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
4:20pm
and reconstructive surgeons since 2010 have created a new standard for safety and patient satisfaction in the over 85 countries in which they are available
424B7
ESTA
Establishment Labs Holdings Inc
31 Jan 24
Prospectus with selling stockholder info
4:33pm
are a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market. We … of adverse events (including rupture, capsular contracture, and safety related reoperations) that we believe compare favorably with those of our competitors
8-K
EX-10.1
ESTA
Establishment Labs Holdings Inc
9 Jan 24
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
4:38pm
or orders affecting employment discrimination, equal opportunity employment, or employees’ health, safety, welfare, wages and hours.
(b)No material
8-K
EX-99.1
gqdtdjahsh
9 Jan 24
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
4:38pm
8-K
EX-99.1
xa9nhsd5znvqeul7
7 Nov 23
Establishment Labs Reports Third Quarter 2023 Financial Results
4:06pm
8-K
EX-99.1
7uzh9qdup xbphk0fk3w
8 Aug 23
Establishment Labs Reports Record Second Quarter 2023 Financial Results
4:08pm
8-K
EX-99.1
u1aruwbpzq hilvny
8 May 23
Establishment Labs Reports Record First Quarter 2023 Financial Results
4:04pm
424B5
i2cwbheyfrt8
26 Apr 23
Prospectus supplement for primary offering
4:05pm
424B5
2zh53u
24 Apr 23
Prospectus supplement for primary offering
4:56pm
S-3ASR
vx0cufcc2zxoy
24 Apr 23
Automatic shelf registration
4:31pm
8-K
EX-99.1
g7r 03fux3zdsl
24 Apr 23
Establishment Labs Announces Preliminary Unaudited Results for First Quarter 2023
4:22pm
8-K
EX-99.1
2lbxi
20 Apr 23
Establishment Labs Notes Presentation of 3-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2023
4:13pm
8-K
EX-10.1
mh6a0cy2y 3i3mw546
2 Dec 22
Departure of Directors or Certain Officers
4:03pm